Crossmark

Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.101903

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Diaz, Luis Antonio

Arab, Juan Pablo

Idalsoaga, Francisco

Perelli, Javiera

Vega, Javier

Dirchwolf, Melisa

Carreño, Javiera

Samith, Bárbara

Valério, Cynthia

Moreira, Rodrigo Oliveira

Acevedo, Mónica

Brahm, Javier

Hernández, Nelia

Gadano, Adrian

Oliveira, Claudia P.

Arrese, Marco

Castro-Narro, Graciela

Pessoa, Mario G.
Funding

Funding for this research was provided by:

Fondo Nacional de Desarrollo Científico y Tecnológico (1241450)

Agencia Nacional de Investigación y Desarrollo
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-03-07
More Information

This article is maintained by: Elsevier

Article Title: Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.101903

Content Type: article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.